Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by 20/20 Biolabs Inc.
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
April 07, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
Tickers
AIDX
20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress
March 31, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
Tickers
AIDX
Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test
March 27, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
Tickers
AIDX
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program
March 24, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
Tickers
AIDX
20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies
March 12, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
Tickers
AIDX
20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities
February 25, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
Tickers
AIDX
20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time
February 20, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
Tickers
AIDX
20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth
February 19, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
Tickers
AIDX
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.